Clinical Trials Logo

Obesity, Infant clinical trials

View clinical trials related to Obesity, Infant.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05868811 Recruiting - Clinical trials for Parent-Child Relations

Music and Child Health and Development

Start date: January 16, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the effects of a music enrichment program on the quality of parent child interactions, a child's motivation to eat, and a child's language environment in 9 to 24 month-old children from low-income families. The main questions it aims to answer are: 1. Does participation in a music enrichment program improve the quality of parent-child interactions? 2. Does participation in a music enrichment program reduce motivation for food 3. Does participation in a music enrichment program improve the quality of the language environment? Participants will: 1. Be randomly assigned to participate in either 2, 8-week semesters of weekly music enrichment classes or play group sessions. 2. At the beginning, after the first 8 weeks and after the second 8 weeks, a researcher will come to the participants house and parent-child pairs will: 1. be video recorded during 10 minutes of playtime and meal time. 2. fill out questionnaires 3. wear a small wearable language recorder for 16 hours 3. At the beginning, after the first 8 weeks and after the second 8 weeks, the parent and child will come to the baby lab and will: 1. Play a computer game to test motivation for food 2. have height and weight measurements collected Researchers will compare the music and play groups to see if there is a difference in the quality of parent child interaction, food motivation or language environment.

NCT ID: NCT05798676 Recruiting - Obesity Clinical Trials

Maternal Characteristics Associated With Child Growth and Adiposity

Start date: May 2, 2019
Phase:
Study type: Observational

The goal of this observational study is to investigate the concentrations of leptin, insulin, liver expressed antimicrobial peptide 2 (LEAP2), and cortisol in plasma and breast milk and their relationship with eating behavior, growth, adiposity and with the levels of these hormones in infants, comparing mothers with normal weight and with pre-pregnancy overweight/obesity. The main question[s] it aims to answer are: - Are maternal hormones associated with child growth and adiposity - Are maternal hormone receptors associated with child growth and adiposity - Are infant hormones and their receptors associated with child growth and adiposity Participants will provide milk and blood samples. Researchers will compare mothers with normal weight and with pre-pregnancy overweight/obesity to see if there are differences in child growth and adiposity .

NCT ID: NCT04991402 Recruiting - Obesity Clinical Trials

Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

ORCHID
Start date: September 21, 2021
Phase:
Study type: Observational

A total of 1900 pregnant women in the 1st trimester and their children will be enrolled and followed for two years (ORCHID study main cohort). As part of this, mother-infant pairs will be required to attend up to 10 study visits separate from routine clinic visits, these visits include 3 antenatal visits (less than or equal to 18, 24-28 and 32-36 weeks) and 16 postnatal visits (<2 and 6 weeks, 3, 6, 12, 18, and 24 months). Participants will also be asked to engage in long-term follow-up, with visits occurring every 6 months through Month 60 (at 30, 36, 42, 48, 54, and 60 months). Measurements in mothers will include demographics and health status, HIV disease and ART use, intercurrent medical history including concomitant medication use, HIV viral load testing, ART adherence, HIV antibody testing in women without HIV; body composition, caloric intake, dysglycemia and insulin resistance (IR), lipid profiles, anthropometry, resting energy expenditure, hepatic steatosis, specimen collection (whole blood, plasma, serum, urine, placenta and breastmilk), systemic and adipose inflammation, as well as metabolites, lipid subspecies and eicosanoids. Measurements in infants will include uterine gestational age and fetal growth, as well as metabolites, lipid subspecies and eicosanoids, body composition, dysglycemia and IR, lipid profiles, anthropometry, feeding, specimen collection (cord blood, whole blood, plasma and serum) and intercurrent medical history including concomitant medication use. Additional data on maternal health in pregnancy and birth outcomes will be abstracted from medical records.